ISO 27001 certification for Thirona assures that patients' data is handled according to stringent information security guidelines
Thirona is awarded ISO 27001 and NEN 7510 certifications.
Thirona appoints Chief Medical Officer
We are very glad to announce that prof. Tiddens has joined Thirona.
Thirona partners with Free Flow Medical for AI-powered clinical solutions to treat COPD patients
Thirona partners with Free Flow Medical
Amazon Web Services supports Thirona's innovation in diagnostic research
Amazon Web Services grants Thirona AWS Promotional Credit under the DDI Program.
Thirona and Pulmonx have extended their strategic partnership, which leverages Thirona’s AI-powered solutions in Pulmonx StratX® platform
Thirona BV and Pulmonx Corporation have extended their long-running strategic partnership.
Thirona’s artery-vein and segment segmentation helps in lung cancer surgeries
Read the new paper on the added value of AI-based lung segmentation and VR technology in lung cancer surgery planning.
Thirona closes financing round with HERAN Partners and Borski Fund
We are proud to inform that we have just closed a financing round with Belgian investment fund HERAN Partners and Borski Fund from the Netherlands.
International distribution partnership with NIDEK
We are pleased to announce our distribution partnership with Nidek CO., LTD., a global leader in the ophthalmic, optometric, and lens edging equipment sphere.
Thirona is present at ATS and Radiology days
Thirona is present during the congress of the American Thoracic Society from May 14-19.
Thirona launches AI software for Cystic Fibrosis
Thirona developed an AI algorithm that revolutionizes cystic fibrosis (CF) care.
LUMC calculates lung damages COVID-19 patients with AI technology
Healthcare professionals at Leiden University Medical Centre can now use artificial intelligence to quickly and easily calculate whether a corona patient has suffered serious lung damage.
Update from Thirona
Due to COVID-19 further spread worldwide, we prepared an update on our work to better bridge the gap between medical image analysis and clinical use-ability.
The Canisius Wilhelmina Ziekenhuis in Nijmegen is now using CAD4COVID-CT in their clinical practice!
Our CAD4COVID software will help to assess affected lung tissue in COVID-19 patients.
CAD4COVID-CT is allowed by the FDA to be used in the US
CAD4COVID-CT can now help even more people with the permission from the FDA.
